0.3889  -0.009 (-2.16%)		11-28 15:03
Open: 0.37 High: 0.4 Volume: 36,006		Pre. Close: 0.3975 Low: 0.37 Market Cap: 5(M)

Short term
Mid term
Targets	6-month :	0.63	1-year :	0.75
Resists	First :	0.54	Second :	0.64
Pivot price	0.42
Supports	First :	0.37	Second :	0.3
MAs	MA(5) :	0.4	MA(20) :	0.43
	MA(100) :	0.7	MA(250) :	0.89
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	16	D(3) :	16.5
RSI	RSI(14): 29.4
52-week	High :	2.14	Low :	0.37

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ IMCC ] has closed above bottom band by 12.0%. Bollinger Bands are 56.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.43 - 0.43	0.43 - 0.43
Low:	0.38 - 0.39	0.39 - 0.39
Close:	0.39 - 0.4	0.4 - 0.4

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.

Mon, 27 Nov 2023
The Daily Hit: November 27, 2023 - Green Market Report

Mon, 27 Nov 2023
IM Cannabis Announces Receipt of Court Action Israel - English - PR Newswire

Fri, 24 Nov 2023
Cannabis memory lane: Who's sticking it out, who's dead and dying - Equity.Guru

Mon, 13 Nov 2023
IM Cannabis Reports Third Quarter 2023 Financial Results Israel ... - PR Newswire

Wed, 08 Nov 2023
IM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ET - Yahoo Finance

Fri, 13 Oct 2023
IM Cannabis Releases a Message from the CEO about the Israel ... - PR Newswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Shares Out	13 (M)
Shares Float	9 (M)
Held by Insiders	34.4 (%)
Held by Institutions	6.1 (%)
Shares Short	16 (K)
Shares Short P.Month	45 (K)

EPS	-2.85
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.42
Profit Margin	-74.7 %
Operating Margin	-18.3 %
Return on Assets (ttm)	-7.2 %
Return on Equity (ttm)	-43.2 %
Qtrly Rev. Growth	-12.7 %
Gross Profit (p.s.)	0.68
Sales Per Share	3.92
EBITDA (p.s.)	-0.57
Qtrly Earnings Growth	0 %
Operating Cash Flow	-10 (M)
Levered Free Cash Flow	15 (M)

PE Ratio	-0.14
PEG Ratio	0
Price to Book value	0.27
Price to Sales	0.09
Price to Cash Flow	-0.51

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.